Cytotoxicity assays shown in Fig. 5A-C were carried out as previously described.43 For screening of ADCs against Antigen C, human cancer cells expressing Antigen C were cultured in EMEM medium (ATCC, Manassas, VA) supplemented with 10% fetal bovine serum, 10 µg/mL insulin (Sigma, St. Louis, MO), penicillin and streptomycin (Mediatech, Herndon, VA). Cells were plated on 384-well plates (Grenier Bio-One #781091, Monroe, NC), at a dilution of 400 cells in 22.5 µL growth medium. The cells were incubated for 16-24 h at 37°C, 5% CO2. ADCs were diluted 1:100 in growth medium, then diluted serially 1:4 and 2.5 µL added to cells in triplicate with a Beckman FX automated liquid handler. Plates were sealed with gas permeable plate seals (Thermo Fisher Scientific #241205, Waltham, MA) and cultured for 5 d at 37°C, 5% CO2. Cell viability was measured by addition of 12.5 µL CellTiter-Glo reagent (Promega #7573, Madison, WI) followed by shaking in the dark for 30 min. The luminescence intensity of the plates read on an Enspire 2300 multimode plate reader (Perkin Elmer, Shelton CT).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.